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 Abstract 33 
Olfactory ensheathing glia (OEG) cells are known to foster axonal regeneration 34 
of central nervous system (CNS) neurons. Several lines of reversibly 35 
immortalized human OEG (ihOEG) have been previously established that 36 
enabled to develop models for their validation in vitro and in vivo. In this work, a 37 
constitutively GFP-expressing ihOEG cell line was obtained, and named Ts14-38 
GFP. Ts14-GFP neuroregenerative ability was similar to that found for the 39 
parental line Ts14 and it can be assayed using in vivo transplantation 40 
experimental paradigms, after spinal cord or optic nerve damage. Additionally, 41 
we have engineered a low-regenerative ihOEG line, hTL2, using lentiviral 42 
transduction of the large T antigen from SV40 virus, denominated from now on 43 
Ts12. Ts12 can be used as a low regeneration control in these experiments. 44 
 45 
Key words: Immortalized human olfactory ensheathing glia (ihOEG); retinal 46 
ganglion neuron (RGN); axonal regeneration; green fluorescent protein (GFP); 47 
proof of concept.48 
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Introduction  49 
From Cajal’s classical studies, it is known that in contrast to neurons from the 50 
peripheral nervous system (PNS), central nervous system (CNS) neurons 51 
regenerate poorly [1]. Several strategies have been used to promote CNS 52 
regeneration [2], but during the last years the use of olfactory ensheathing glía 53 
(OEG) for CNS regeneration has received much attention due to their special 54 
properties [2-7]. These cells have been described to derive either from the 55 
olfactory placode [8] or, in contrast, the neural crest [9]. Since throughout life 56 
OEG usually surrounds olfactory axons growing into the adult mammalian CNS, 57 
it was reasonable to hypothesise that they might facilitate axonal regeneration 58 
[2-4,6,10-13]. In fact, several studies have confirmed their neuroregenerative 59 
and neuroprotective capacities in different models of CNS injury [14-19]. This 60 
OEG reparative capacity is due to a combination of several factors [2,3], 61 
including inflammation/angiogenesis control, astrocytes interaction [2,20-22], 62 
glial scar decrease [2,20], extracellular matrix proteases production [23], 63 
secretion of neurotrophic [24-26] and axonal growing factors [27], and ability to 64 
promote myelination [28].  65 
Given the technical limitations to expand primary OEG, maintaining the 66 
regenerative properties for transplantation [3], we have previously described the 67 
establishment of several immortalized OEG clonal lines (iOEG) derived from 68 
primary cultures prepared from rat olfactory bulb [29]. These lines provide an 69 
unlimited supply of homogeneous OEG cells and maintain the regenerative 70 
capacity of the original cultures both i) in vitro, in a model of adult axonal 71 
regeneration in cocultures of OEG lines with adult RGNs [23,29,30]; and ii) in 72 
vivo in a model of spinal cord injury and transplantation [31]. We extended 73 
these studies to human OEG (hOEG), describing the preparation of primary 74 
cultures from olfactory bulbs obtained in autopsies. These primary cells were 75 
reversibly immortalized using the genes of telomerase catalytic subunit (TERT) 76 
and Bmi-1, obtaining several ihOEG cell lines that conserved their 77 
neuroregenerative properties (ihOEG hTLs) [32,33]. hTL4 cells were 78 
additionally modified with the SV40 virus large T antigen [34], originating in this 79 
way  a Ts14 OEG cell line, with rapid growth capacity. This line provided an 80 
excellent tool for the study of OEG properties in vitro [34].  81 
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Previously, we also demonstrated that hTL4 cells engineered to constitutively 82 
express green fluorescent protein (GFP) can be tracked several weeks after 83 
xenotransplantation in the injured spinal cord of nude rats [32]. In the future, we 84 
aim to follow Ts14 cells after transplantation in the injured CNS (i.e. spinal cord 85 
or optic nerve). We describe here: i) the additional modification of Ts14 line, 86 
engineering it to constitutively express GFP; and ii) the generation of a 87 
modification of the previously described [32] low-regenerative ihOEG line hTL2, 88 
using lentiviral transduction of the SV40 virus large T antigen, thus originating 89 
the Ts12 ihOEG line. Using our in vitro coculture model as a proof of concept, 90 
we have determined preservation of i) neuroregenerative capacity of Ts14-GFP 91 
line in comparison with its parental line Ts14, and ii) the low-regenerative 92 
capacity of Ts12 line.93 
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2. Materials and methods 94 
2.1. Animals 95 
All animal experimentation was carried out in animal facilities of UFV complying 96 
with the Spanish Royal Decree 223/1988, which follows the European Council 97 
Directive 86/609/EEC (1986), and approved by national and institutional 98 
bioethics committees. Animals were maintained on a 12-hour light/12-hour dark 99 
cycle in a day, and were supplied with regular food and water ad libitum. 100 
2.2. Cell cultures 101 
ihOEG Cell line Ts14 was maintained as previously described, using ME10 102 
[29,30], composed by DMEM-F12 medium supplemented with 10% foetal calf 103 
serum (FCS) Hyclone (ThermoScientific), 2mM glutamine  (Thermoscientific), 104 
20 µg/mL pituitary extract (Gibco, Life Technologies), 2 μM forskolin (Sigma) 105 
and antibiotics (Primocin 100 µg/mL and Plasmocin 25 µg/mL, Invivogen) at 106 
37ºC in 5% CO2. 107 
2.3. Immunostaining 108 
Cells were plated in coverslips and after 24-48 hours were fixed with 4% 109 
paraformaldehyde (PFA) in phosphate buffered saline (PBS). After several 110 
washes with PBS, immunocytochemistry was performed. Briefly, cells were 111 
blocked with 0,1% Triton X-100/1% FCS in PBS (PBS-TS). Primary antibodies 112 
were prepared in this buffer as follows: mouse monoclonal antibodies against 113 
S100β (1:500, SIGMA), Neuroligin-3 (1:1000, Synaptic Systems), SV40 Large T 114 
antigen (1:250, Pharmingen) and GFP (1:1000, Cell Signalling); and rabbit 115 
polyclonal antibody against GFAP (glial fibrillary acidic protein, 1:1000; 116 
Chemicon). After several washes with PBS, cells were incubated with the 117 
corresponding fluorescent secondary antibodies prepared in PBS-TS 118 
(conjugated with either alexa 488 or alexa 594 fluorophores). Finally, coverslips 119 
were washed and mounted with Fluoromount (Southern Biotech, Birmingham, 120 
AL). 121 
 In some cases, fluorescent nuclei staining with DAPI (4’,6-Diamidino-2-122 
phenylindole) was performed after incubation with secondary antibodies. After 123 
washing, cells were incubated for 10 minutes in dark with DAPI (10 μg mL-1 in 124 
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PBS/0,1% FCS/0,01% Triton X-100). Then, coverslips were washed and 125 
mounted with Fluoromount. 126 
2.4. Lentiviral vectors packaging using HEK-293T cells 127 
The packaging plasmid pCMVdR8.74 [35] and the vesicular stomatitis virus G 128 
envelope protein plasmid pMD2G (Addgene plasmid 12259) were kindly 129 
supplied by Dr. Filip Lim. Production and purification of pRRLSIN.cPPT.PGK-130 
GFP.WPRE vector (Addgene plasmid 12252) was performed using Quiagen 131 
columns and later plasmid preparations were assayed with restriction 132 
endonucleases and electrophoresis in agarose gel (data not shown).  133 
Lentivectors encoding E-GFP and large T antigen from SV40 (T-SV40) were 134 
produced by transient co-transfection of 5 μg of the pRRLSIN.cPPT.PGK-135 
GFP.WPRE vector or pLOX-Ttag-iresTK vector, which express E-GFP and 136 
SV40 large T antigen, respectively; 5 μg of the packaging plasmid pCMVdR8.74 137 
and 2 μg of the plasmid pMD2G in 10-cm plates of sub-confluent HEK 293T 138 
cells, using Lipofectamine Plus reagent following instructions of the supplier 139 
(Invitrogen). After 48 hours, supernatant with the infectious particles was 140 
recovered, aliquoted and frozen at -80ºC. Lentivectors were titered on target 141 
cells (hOEG) with serial dilutions of the vector supernatants, and the number of 142 
transduced cells was determined 48 hours post-infection by flow cytometry. 143 
2.5. Lentiviral Infection and Ts14-GFP and Ts12 selection 144 
Ts14-GFP and Ts12 cell lines were generated by infecting Ts14 and hTL2 145 
lines with E-GFP and LargeT-SV40 encoding lentivirus, respectively. A 146 
multiplicity of infection (MOI) of 10 infectious units/cell was used, and incubation 147 
was performed during 4-6 hours in DMEM-10% FCS (M10), without tissue 148 
extracts. 149 
Ts14 cells were washed in M10 and maintained for 48 hours, for transgene 150 
expression. Ts14 cells exhibiting high E-GFP expression were selected by flow 151 
cytometry (FACS: Fluorescence-Activated Cells Sorting; FACSVantage SE), 152 
and this line was named as Ts14-GFP. In the case of infected hTL2 cells, they 153 
were washed in M10, maintained in M10 for two weeks after the infection, and 154 
then changed to complete medium ME10 (with tissue extracts), until a 155 
population of rapidly growing cells was selected. This line was named as Ts12. 156 
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Both cell lines, Ts14-GFP and Ts12 were tested to assess their 157 
neuroregenerative capacity in vitro, using Ts14 as a positive control (coculture 158 
model, proof of concept). 159 
2.6. Axonal Regeneration Assay in vitro: coculture of RGN with ihOEG (Ts14, 160 
Ts14-GFP and Ts12) 161 
Adult RGN regenerate their axons very poorly in culture on poly-L-Lysine 162 
(PLL), but plated onto OEG monolayers are able to outgrowth many neurites 163 
(dendrites and long axons). Cocultures of adult rat RGN (p60 animals) with 164 
monolayers of ihOEG, Ts14, Ts14-GFP and Ts12, were performed as 165 
previously described [23,29,36]. Briefly, retinal tissue was extracted from adult 166 
2 month-old rats and digested with papain (20 U/ml papain; Worthington, 167 
Lakewood, NJ) in the presence of 50 μM of the NMDA receptor inhibitor, D,L-2-168 
amino-5-phosphonovaleric acid (Sigma). The mixed retinal cell suspension was 169 
then plated on either 10 μg/ml PLL-treated coverslips or onihOEG: Ts14, Ts14-170 
GFP and Ts12 monolayers. Cultures were maintained at 37°C with 5% CO2 for 171 
96 hr. in serum-free Neurobasal medium (Invitrogen, Carlsbad, CA, USA) 172 
supplemented with B-27 (Invitrogen) and 25 mM KCl (NB-B27), before they 173 
were fixed with 4% PFA in PBS. Then, immunocytochemistry for axonal (SMI31 174 
epitope in MAP1B and neurofilament) and somatodendritic (MAP2A/B, 514 175 
antibody) markers, was performed.  176 
Axonal regeneration was quantified as percentage of neurons with axon 177 
(SMI31 positive neurite) respect to total population of RGNs (identified with 178 
MAP2A/B, 514 positive immunostaining of neuronal body and dendrites). 179 
Additionally, mean axonal length was determined using the application NeuronJ 180 
of the software ImageJ (Wayne Rasband, National Institutes of Health, USA). 181 
Axonal regeneration index was calculated as mean axonal length (μm)/neuron. 182 
Neuron adherence/survival values were estimated by counting the number of 183 
neurons per field (magnification x400). At least 200 neurons or 20 fields were 184 
quantified by taking a picture in a CCD monochrome and colour (Spot ST, 185 





2.7. Statistical Analysis 189 
Analysis of variance (ANOVA) for each parameter quantified was performed to 190 
test the differences between experimental culture conditions (ihOEG cell 191 
monolayers and PLL). If differences were significant, post hoc Tukey test for 192 
multiple comparisons between means was carried out.193 
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3. Results 194 
3.1. Infection and FACS selection of GFP positive Ts14. 195 
Ts14 and Ts12 lines derive from ihOEG hTL4 and hTL2 clonal lines, 196 
respectively, that were reversible immortalized with genes Bmi-1 and TERT 197 
(Fig. 1A shows Ts14 and Ts12 lineage). These lines express OEG typical 198 
markers: S100β (Fig. 1A), GFAP and Neuroligin [32,34].  199 
Ts12 was obtained using SV40 large T antigen lentiviral transduction of hTL2 200 
cell line, and selecting with the passages a population with rapid growing 201 
capacity (Fig 1A). Population doubling for these cells was determined to be 202 
around 20 hours.  203 
Ts14 was infected with a lentivirus carrying E-GFP gene (Fig. 1A) and a 204 
positive population was isolated using flow cytometry and cell sorting (FACS). 205 
Ts14 cell line transduced with GFP represented 22.5% of the total population. 206 
FACS isolated Ts14-GFP cells were separated again using this technique to 207 
assure that all selected cells expressed GFP.  208 
Both Ts12 and Ts14 presented nuclear expression of SV40 virus large T 209 
antigen (Fig. 1B and C). 210 
3.2. Axonal Regeneration Assay in vitro: coculture of RGN with ihOEG 211 
In one set of experiments, regenerative capacity of ihOEG line Ts12 was 212 
compared with the regenerative Ts14 line, in seven independent cocultures. 213 
RGN adherence/survival values were 6.38±0.67 for Ts14 and 9.79±1.98 for 214 
Ts12 (neurons/field, mean ± S.E.M.; Fig. 2A). Percentages of neurons with an 215 
axon were 15.41±1.40% and 6.20±0.96% for Ts14 and Ts12, respectively 216 
(mean ± S.E.M, p < 0.001, Anova and post-hoc Tukey test; Figs. 2B, 2D and 217 
2E). Finally, axonal length/neuron in Ts14 and Ts12 were 47.08±5.82 and 218 
12.88±4.11 μm/neuron, respectively (mean ± S.E.M, p < 0.001, Anova and 219 
post-hoc Tukey test; Figs. 2C, 2D and 2E).  On PLL we obtained a high, but not 220 
significant (Anova) RGN adherence value (11.20±2.01 neurons/field, mean ± 221 
S.E.M, Fig. 2A), but very low axonal regeneration was observed, as assessed 222 
by percentage of neurons with an axon (2.86±0.33%; mean ± S.E.M., p < 0.001, 223 
Anova and post-hoc Tukey test, vs. value obtained for Ts14; p = 0.07 Tukey 224 
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test vs. value obtained for Ts12; Figs. 2B and 2F) and axonal length/neuron 225 
(3.13±0.91 μm/neuron, mean ± S.E.M., p < 0.001, Anova and post-hoc Tukey 226 
test, vs. values obtained for Ts14; p > 0.05 Tukey test vs. value obtained for 227 
Ts12; Figs. 2C and 2F).  228 
In another set of experiments, Ts14 and Ts14-GFP capacities to induce RGN 229 
axonal regeneration were compared in four independent cocultures, to 230 
determine if GFP gene insertion affected the neuroregenerative ability of this 231 
new line. RGN adherence/survival values were 8.89±0.81 for Ts14 and 232 
8.86±1.21 for Ts14-GFP (neurons/field, mean ± S.E.M., p > 0.05, Anova and 233 
post-hoc Tukey test; Fig. 3A). Percentages of neurons with an axon were 234 
13.04±1.32% and 12.44±0.67% for Ts14 and Ts14-GFP, respectively (mean ± 235 
S.E.M., p > 0.05, Anova and post-hoc Tukey test; Figs. 3B, 3D and 3E). Finally, 236 
axonal length/neuron on Ts14 and Ts14-GFP were 38.47±8.89 and 34.62±9.10, 237 
respectively (μm/neuron, mean ± S.E.M. p > 0.05, Anova and post-hoc Tukey 238 
test; Figs. 3C, 3D and 3E). Newly, in PLL we obtained a high RGN adherence 239 
value (16.91±3.09 neurons/field, mean ± S.E.M. p < 0.05, Anova and post-hoc 240 
Tukey test vs. values obtained for Ts14 and Ts14-GFP, Fig. 3A), but low axonal 241 
regeneration, as assessed by percentage of neurons with an axon 242 
(1.13±0.65%; mean ± S.E.M., p < 0.001, Anova and post-hoc Tukey test vs. 243 
values obtained for Ts14 and Ts14-GFP; Figs. 3B, 3F) and axonal 244 
length/neuron (1.70±1.02 μm/neuron, mean ± S.E.M., p = 0.016  and p = 0.028, 245 
Anova and post-hoc Tukey test vs. values obtained for Ts14 and Ts14-GFP, 246 
respectively; Figs. 3C, 3F).247 
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4. Discussion 248 
We have previously described ihOEG lines to promote adult RGN axonal 249 
regeneration in vitro [32-34]. These human glial lines enable us to study the 250 
molecular mechanisms  responsible for their neuroregenerative properties: in 251 
the case of hTL4 line we identified the pathway of PAR-1 and, associated to 252 
this, the role of PAI-1 [27]. However, hTLs growing rate in culture is similar to 253 
the primary cultures, with a population doubling time of  ten days, approximately 254 
[32]. For this reason we have modified some hTL lines by viral transduction of 255 
the SV40 Large T antigen. In this way, we originated from hTL4 and hTL2 the 256 
lines arbitrarily named Ts14 [34] and Ts12 (described here), respectively. Both 257 
lines have a high growing capacity, with a population doubling time around 20-258 
24 hours. Therefore, Ts14 provides an excellent tool to study ihOEG 259 
regenerative properties, both in vitro [34] and in animal models of CNS lesion.  260 
Here, we aimed to modify Ts14 line, engineering it to constitutively express 261 
GFP. With this modification we will be able to track these regenerative cells in 262 
transplantation models after spinal cord and optic nerve injury. Then, we have 263 
evaluated the regenerative capacity of Ts14-GFP in comparison with its 264 
parental line Ts14, and using Ts12 as a low regeneration control cell. We 265 
demonstrate that the insertion of the GFP gene in the Ts14 genome did not 266 
change the regenerative properties of the new line, and that this is also true 267 
when we compare it with our other previously described ihOEG [32-34]. Thus, 268 
this new Ts14-GFP line is adequate for testing its neuroregenerative capacity 269 
and for cell tracking in in vivo models of CNS injury. By contrast, we have 270 
demonstrated here that Ts12 is a line that presents low neuroregenerative 271 
ability in our model of coculture with RGN, as its parental line hTL2 [32].  272 
Previously, our group found differences after OEG immortalization between 273 
hTL lines, being precisely hTL2 a low-regenerative line. OEG primary cultures 274 
are heterogeneous, and because hTL2 is a clonal line, we cannot discard the 275 
random selection of a non-regenerative cell of the original culture. However, 276 
other possible explanation is that insertion of “immortalizing” genes in the 277 
genome of the original OEG cell may have disturbed genetic information 278 
fundamental for hTL2 regenerative capacity [32]. The additional engineering of 279 
this line to express SV40 large T antigen did not modify the lack of 280 
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neuroregenerative capacity, as expected. Because gene transfer mediated by 281 
lentivectors does not permit to control integration sites or copy number 282 
insertion, a proof of concept must be performed:  newly modified selected lines 283 
must be evaluated to assess preservation of their neuroregenerative properties.  284 
In conclusion, i) our work provides us with a low-regenerative ihOEG line as a 285 
control for axonal regeneration studies (in vitro and in vivo); and ii) this study 286 
constitutes a proof of concept and confirms that the ihOEG line Ts14-GFP 287 
maintains the ability to induce axonal regeneration, as its direct parental Ts14 288 
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FIGURE LEGENDS 409 
Figure 1. Human Immortalized OEG (ihOEG) lines, named hTLs, were obtained 410 
by reversible immortalization with Bmi1 and TERT genes, from primary human 411 
OEG cell culture [32]. Afterwards, hTL4 [34] and hTL2 were modified by 412 
lentiviral transfer with SV40 large T antigen, originating in this way Ts14 and 413 
Ts12 ihOEG lines (A). Finally, we have additionally modified Ts14 line to 414 
constitutively express green fluorescent protein (EGFP: Enhanced Green 415 
Fluorescent Protein). S100β and GFP immunostaining, and DAPI nuclear 416 
staining of primary culture cells, are shown in the figure (A). ihOEG lines Ts12 417 
(B) and Ts14 (C) in culture express nuclear SV40 virus large T antigen. Bars 50 418 
μm. 419 
Figure 2. Quantification of axonal regeneration was performed in cocultures of 420 
RGN with Ts14 and Ts12. Number of neurons per field (A), percentage of 421 
neurons with an axon (B), and mean axonal length, expressed as μm/neuron 422 
(C) were quantified (PLL: Poly-L-Lysine, 10 μg/ml). Means ± S.E.M. of 7 423 
experiments, with duplicated samples for each experimental condition, are 424 
shown. Asterisks indicate the statistical significance: ***p < 0.001 (ANOVA and 425 
post hoc Tukey test comparisons between parameters quantified for Ts14 vs. 426 
Ts12 and for Ts14 vs. PLL. There was not statistical difference between the 427 
numbers of neurons per field in the different conditions). Cocultures of RGN 428 
with Ts14 (D) or Ts12 (E) and RGN on PLL 10 µg/mL (F) are shown. White 429 
arrows indicate RGN axons (SMI31-positive: green) and blue arrows neuronal 430 
bodies and dendrites (514 positive: red and yellow). Bar 50 μm. 431 
Figure 3. Quantification of axonal regeneration was performed in cocultures of 432 
RGN with Ts14 and Ts14-GFP. Number of neurons per field (A), percentage of 433 
neurons with an axon (B), and mean axonal length, expressed as μm/neuron 434 
(C) were quantified (PLL: Poly-L-Lysine, 10 μg/ml). Means ± S.E.M. of 4 435 
experiments, with duplicated samples for each experimental condition, are 436 
shown. Asterisks indicate the statistical significance: ***p < 0.001 and *p < 0.05 437 
(ANOVA and post hoc Tukey test comparisons between parameters quantified 438 
for Ts14 and Ts14-GFP vs. PLL. There was not significant difference between 439 
values obtained for Ts14 and Ts14-GFP). Cocultures of RGN with Ts14 (D) or 440 
Ts14-GFP (E) and RGN on PLL 10 µg/mL (F) are shown. White arrows indicate 441 
19 
 
RGN axons (SMI31-positive: red) and blue arrows neuronal bodies and 442 
dendrites (514-positive: green). Bar 50 μm. 443 
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